Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Sebastian J. Swic, Alexander G. T. MacPhail, Chinmay B. Dalal, MD, Steven J.T. Huang, BMLSc, Alina S. Gerrie, MD FRCPC, Thomas J. Nevill, MD, Heather J. Sutherland, MD PhD FRCPC, Raewyn Broady, MBChB, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Kevin Song, MD, Yasser R Abou Mourad, MD FRCPC, Donna E. Hogge, MD PhD FRCPC, Maryse M. Power, MD MRCPI, FRCPath, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD, Sean S Young, PhD DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD FCCMG, Cynthia L. Toze, MD FRCPC

Blood (2014) 124 (21): 2549.

https://doi.org/10.1182/blood.V124.21.2549.2549

Published: 2014

Journal Articles

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Krystal Bergin, MBBS, Alina S. Gerrie, MD, FRCPC, Steven J.T. Huang, BMLSc, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Aly Karsan, MD, Monica Anne Hrynchak, MD, FRCP(C), Chinmay B. Dalal, MD, Helene Bruyere, MD, FCCMG, Adam C. Smith, PhD, FCCMG, FACMG, Cynthia L. Toze, MD, MHSc, FRCPC, Tanya L. Gillan, PhD, FCCMG

Blood (2012) 120 (21): 1401.

https://doi.org/10.1182/blood.V120.21.1401.1401

Published: 2012

Journal Articles

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Alina S. Gerrie, MD, FRCPC, MPH, Steven J.T. Huang, BMLSc, Helene Bruyere, MD, FCCMG, Chinmay B. Dalal, MD, Monica Anne Hrynchak, MD, FRCP(C), Aly Karsan, MD, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Adam C. Smith, PhD, FCCMG, FACMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, FRCP(C)

Blood (2012) 120 (21): 3897.

https://doi.org/10.1182/blood.V120.21.3897.3897

Published: 2012

Journal Articles

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Chinmay B. Dalal, MD, Chandrakala Shanmukhaiah, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, FRCPC, Donna L. Forrest, MD, FRCPC, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, FRCPC, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, MRCPI, FRCPath, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Yasser R Abou Mourad, MD, FRCPC, John D. Shepherd, MD, FRCPC, Sean S Young, PhD, DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, MHSc, FRCPC

Blood (2012) 120 (21): 4132.

https://doi.org/10.1182/blood.V120.21.4132.4132

Published: 2012

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality

Alina S. Gerrie, MD, FRCPC, Tanya L. Gillan, PhD, FCCMG, Helene Bruyere, MD, FCCMG, Mary Joyce Chan, BMLSc, Chinmay B. Dalal, MD, Cynthia L. Toze, MD, FRCPC

Blood (2010) 116 (21): 2434.

https://doi.org/10.1182/blood.V116.21.2434.2434

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Cynthia Toze, MD, FRCPC, Chinmay B. Dalal, MD, Tanya L. Gillan, PhD, FCCMG, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, Donna L. Forrest, MD, Heather Sutherland, MD, PhD, FRCPC, Kevin Song, MD, Raewyn Broady, MBChB, FRACP, Maryse Power, MD, FRCPath, Sujaatha Narayanan, MD, Clayton A. Smith, MD, FRCPC, John Shepherd

Blood (2010) 116 (21): 3465.

https://doi.org/10.1182/blood.V116.21.3465.3465

Published: 2010

NARROW

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only